Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.63% | -0.26% | -6.79% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.79% | 9.32B | |
-4.36% | 182B | |
+1.69% | 110B | |
-2.35% | 68.11B | |
+2.63% | 50.53B | |
+9.69% | 44.8B | |
+2.84% | 40.7B | |
+21.84% | 32.25B | |
+3.50% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen Appoints Jason K. Garland as Chief Financial Officer